A recent study demonstrated a negative correlation of CES2 expression and intracellular lysophosphatidylcholine (lysoPC) and DAG levels [21,22] in cancer cell lines and another study discovered lysoPC (16:0) as a PPARg ligand [23]. Here, CES2 is linked to cancer.